FI113966B - Pyrrolo [2,1-b] imidatsoli-, ja -tiatsoli- ja pyrrolo [2,1-b] -1,3-tiatsiinijohdannaiset ja niiden käyttö farmasiassa ja välituotteina - Google Patents
Pyrrolo [2,1-b] imidatsoli-, ja -tiatsoli- ja pyrrolo [2,1-b] -1,3-tiatsiinijohdannaiset ja niiden käyttö farmasiassa ja välituotteina Download PDFInfo
- Publication number
- FI113966B FI113966B FI964772A FI964772A FI113966B FI 113966 B FI113966 B FI 113966B FI 964772 A FI964772 A FI 964772A FI 964772 A FI964772 A FI 964772A FI 113966 B FI113966 B FI 113966B
- Authority
- FI
- Finland
- Prior art keywords
- phenyl
- pyrrolo
- formula
- thiazole
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Diabetes (AREA)
- Dermatology (AREA)
- Hematology (AREA)
- Neurosurgery (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Peptides Or Proteins (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4419315A DE4419315A1 (de) | 1994-06-01 | 1994-06-01 | Heteropyrrolizinverbindungen und deren Anwendung in der Pharmazie |
DE4419315 | 1994-06-01 | ||
PCT/EP1995/002078 WO1995032971A1 (de) | 1994-06-01 | 1995-05-31 | [a]-ANNELIERTE PYRROLDERIVATE UND DEREN ANWENDUNG IN DER PHARMAZIE |
EP9502078 | 1995-05-31 |
Publications (3)
Publication Number | Publication Date |
---|---|
FI964772A0 FI964772A0 (fi) | 1996-11-29 |
FI964772A FI964772A (fi) | 1997-01-27 |
FI113966B true FI113966B (fi) | 2004-07-15 |
Family
ID=6519632
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI964772A FI113966B (fi) | 1994-06-01 | 1996-11-29 | Pyrrolo [2,1-b] imidatsoli-, ja -tiatsoli- ja pyrrolo [2,1-b] -1,3-tiatsiinijohdannaiset ja niiden käyttö farmasiassa ja välituotteina |
Country Status (13)
Country | Link |
---|---|
US (1) | US5939415A (no) |
EP (1) | EP0804437B1 (no) |
JP (1) | JP3569823B2 (no) |
KR (1) | KR100378882B1 (no) |
AT (1) | ATE304543T1 (no) |
AU (1) | AU2672995A (no) |
CA (1) | CA2191745A1 (no) |
DE (2) | DE4419315A1 (no) |
DK (1) | DK0804437T3 (no) |
ES (1) | ES2248798T3 (no) |
FI (1) | FI113966B (no) |
NO (1) | NO311222B1 (no) |
WO (1) | WO1995032971A1 (no) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998032756A1 (en) * | 1997-01-22 | 1998-07-30 | Ciba Specialty Chemicals Holding Inc. | Substituted aminoalkylidenamino triazines as herbicides |
JP2003505390A (ja) | 1999-11-23 | 2003-02-12 | メルクル・ゲーエムベーハー | 抗炎症薬用のピロリジンのオキソ及びヒドロキシ誘導体、並びにその使用方法 |
DE10001166A1 (de) * | 2000-01-13 | 2001-07-19 | Merckle Gmbh | Anellierte Pyrrolverbindungen, diese enthaltende pharmazeutische Mittel und deren Verwendung |
EA004938B1 (ru) * | 2000-01-28 | 2004-10-28 | Меркле Гмбх | Способ получения 6-(4-хлорфенил)-2,2-диметил-7-фенил-2,3-дигидро-1h-пирролизин-5-илуксусной кислоты |
DE10004157A1 (de) * | 2000-02-01 | 2001-08-02 | Merckle Gmbh Chem Pharm Fabrik | 4-Pyridyl-und 2,4-Pyrimidinyl-substituierte Pyrrolderivate und ihre Anwendung in der Pharmazie |
DE10141285A1 (de) | 2001-08-23 | 2003-03-27 | Merckle Gmbh | Verfahren zur Herstellung von 6-(4-Chlorphenyl)-2,2-dimethyl-7-phnyl-2,3-dihydro-1H-pyrrolizin-5-yl-essigsäure |
US7425573B2 (en) | 2001-08-30 | 2008-09-16 | Merckle Gmbh | Use of annellated pyrrole compounds in the treatment of articular cartilage or subchondral bone degeneration |
US6953787B2 (en) * | 2002-04-12 | 2005-10-11 | Arena Pharmaceuticals, Inc. | 5HT2C receptor modulators |
SI2332921T1 (sl) | 2003-06-17 | 2016-06-30 | Arena Pharmaceuticals, Inc. | 8-kloro-1-metil-2,3,4,5-tetrahidro-1H-3-benzazapin hidroklorid |
CN101274911B (zh) * | 2003-06-17 | 2011-01-26 | 艾尼纳制药公司 | 用于治疗5ht2c受体相关病症的苯并氮杂卓衍生物 |
WO2005042490A1 (en) * | 2003-10-22 | 2005-05-12 | Arena Pharmaceuticals, Inc. | Benzazepine derivatives and methods of prophylaxis or treatment of 5ht2c receptor associated diseases |
WO2005042491A1 (en) * | 2003-10-22 | 2005-05-12 | Arena Pharmaceuticals, Inc. | Benzazepine derivatives and methods of prophylaxis or treatment of 5ht2c receptor associated diseases |
JP5270167B2 (ja) | 2004-12-21 | 2013-08-21 | アリーナ ファーマシューティカルズ, インコーポレイテッド | (r)−8−クロロ−1−メチル−2,3,4,5−テトラヒドロ−1h−3−ベンザゼピン塩酸塩の結晶形 |
KR20130087622A (ko) * | 2004-12-23 | 2013-08-06 | 아레나 파마슈티칼스, 인크. | 5ht2c 수용체 조정물질 조성물 및 그의 사용 방법 |
DE102005012971A1 (de) | 2005-03-21 | 2006-09-28 | Merckle Gmbh | Polymorphe Form von 6-(4-Chlorphenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-yl-essigsäure |
CN101466684B (zh) * | 2006-04-03 | 2012-06-20 | 艾尼纳制药公司 | 8-氯-1-甲基-2,3,4,5-四氢-1h-3-苯并氮杂卓的制备工艺和其相关中间体 |
WO2008070111A2 (en) * | 2006-12-05 | 2008-06-12 | Arena Pharmaceuticals, Inc. | Processes for preparing (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine and intermediates thereof |
WO2009111004A1 (en) * | 2008-03-04 | 2009-09-11 | Arena Pharmaceuticals, Inc. | Processes for the preparation of intermediates related to the 5-ht2c agonist (r)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1h-3-benzazepine |
US8952197B2 (en) | 2009-06-18 | 2015-02-10 | Arena Pharmaceuticals, Inc. | Processes for the preparation of 5-HT2C receptor agonists |
KR20130112848A (ko) | 2010-06-02 | 2013-10-14 | 아레나 파마슈티칼스, 인크. | 5-ht2c 수용체 아고니스트의 제조 방법 |
NZ630494A (en) | 2010-09-01 | 2016-05-27 | Arena Pharm Inc | Administration of lorcaserin to individuals with renal impairment |
SG188362A1 (en) | 2010-09-01 | 2013-04-30 | Arena Pharm Inc | Modified-release dosage forms of 5-ht2c agonists useful for weight management |
SG10201506870PA (en) | 2010-09-01 | 2015-10-29 | Arena Pharm Inc | Salts of lorcaserin with optically active acids |
SG188361A1 (en) | 2010-09-01 | 2013-04-30 | Arena Pharm Inc | Non-hygroscopic salts of 5-ht2c agonists |
KR20150070249A (ko) | 2012-10-09 | 2015-06-24 | 아레나 파마슈티칼스, 인크. | 체중 관리 방법 |
KR20150143104A (ko) | 2014-06-13 | 2015-12-23 | 이경희 | 원적외선을 이용한 건식 발 온열기 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SU417424A1 (no) * | 1972-02-03 | 1974-02-28 | ||
GB1461592A (en) * | 1973-04-25 | 1977-01-13 | Agfa Gevaert | Specially sensitized direct positive silver halide emulsions |
US3920672A (en) * | 1974-08-22 | 1975-11-18 | Syntex Inc | Thiacycl (2.2.2.)azine carboxylic acids |
US4536512A (en) * | 1982-10-08 | 1985-08-20 | Merck & Co., Inc. | 5-(2,3-Dihydro-1H-pyrrolizin-5-oyl)-2,3-dihydro-1H-pyrrolizine-1-alkanoic or carboxylic acids and use thereof as anti-inflammatory and analgesic agents |
DD216021A5 (de) * | 1983-01-13 | 1984-11-28 | Rhone Poulenc Sante | Verfahren zur herstellung eines neuen pyrrolderivates |
FR2557111B1 (fr) * | 1983-12-21 | 1986-04-11 | Rhone Poulenc Sante | Nouveaux derives ortho-condenses du pyrrole, leur preparation et les medicaments qui les contiennent |
DE3915450A1 (de) * | 1989-05-11 | 1990-11-15 | Gerd Prof Dr Dannhardt | Substituierte pyrrolverbindungen und deren anwendung in der pharmazie |
US5260451A (en) * | 1989-05-11 | 1993-11-09 | Merckle Gmbh | Substituted pyrrole compounds and use thereof in pharmaceutical compositions |
DE69419327D1 (de) * | 1993-01-21 | 1999-08-12 | Konishiroku Photo Ind | Ein farbphotographisches Silberhalogenidmaterial |
US5552422A (en) * | 1995-01-11 | 1996-09-03 | Merck Frosst Canada, Inc. | Aryl substituted 5,5 fused aromatic nitrogen compounds as anti-inflammatory agents |
-
1994
- 1994-06-01 DE DE4419315A patent/DE4419315A1/de not_active Withdrawn
-
1995
- 1995-05-31 JP JP50033396A patent/JP3569823B2/ja not_active Expired - Fee Related
- 1995-05-31 US US08/737,920 patent/US5939415A/en not_active Expired - Fee Related
- 1995-05-31 AU AU26729/95A patent/AU2672995A/en not_active Abandoned
- 1995-05-31 DK DK95921800T patent/DK0804437T3/da active
- 1995-05-31 KR KR1019960706837A patent/KR100378882B1/ko not_active IP Right Cessation
- 1995-05-31 CA CA002191745A patent/CA2191745A1/en not_active Abandoned
- 1995-05-31 EP EP95921800A patent/EP0804437B1/de not_active Expired - Lifetime
- 1995-05-31 DE DE59511017T patent/DE59511017D1/de not_active Expired - Fee Related
- 1995-05-31 AT AT95921800T patent/ATE304543T1/de not_active IP Right Cessation
- 1995-05-31 WO PCT/EP1995/002078 patent/WO1995032971A1/de active IP Right Grant
- 1995-05-31 ES ES95921800T patent/ES2248798T3/es not_active Expired - Lifetime
-
1996
- 1996-11-29 FI FI964772A patent/FI113966B/fi active
- 1996-11-29 NO NO19965094A patent/NO311222B1/no unknown
Also Published As
Publication number | Publication date |
---|---|
EP0804437B1 (de) | 2005-09-14 |
EP0804437A1 (de) | 1997-11-05 |
WO1995032971A1 (de) | 1995-12-07 |
JP3569823B2 (ja) | 2004-09-29 |
KR100378882B1 (ko) | 2003-08-02 |
ATE304543T1 (de) | 2005-09-15 |
DK0804437T3 (da) | 2005-11-14 |
FI964772A0 (fi) | 1996-11-29 |
JPH10506369A (ja) | 1998-06-23 |
ES2248798T3 (es) | 2006-03-16 |
US5939415A (en) | 1999-08-17 |
NO311222B1 (no) | 2001-10-29 |
NO965094L (no) | 1996-12-11 |
DE59511017D1 (de) | 2005-10-20 |
FI964772A (fi) | 1997-01-27 |
AU2672995A (en) | 1995-12-21 |
NO965094D0 (no) | 1996-11-29 |
KR970703345A (ko) | 1997-07-03 |
CA2191745A1 (en) | 1995-12-07 |
DE4419315A1 (de) | 1995-12-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI113966B (fi) | Pyrrolo [2,1-b] imidatsoli-, ja -tiatsoli- ja pyrrolo [2,1-b] -1,3-tiatsiinijohdannaiset ja niiden käyttö farmasiassa ja välituotteina | |
FI114099B (fi) | Pyrrolitsiini- ja pyrrolo[2,1-b] tiatsolijohdannaiset ja niiden käyttö farmasiassa | |
KR101081446B1 (ko) | 2-치환페닐-5,7-디알킬-3,7-디하이드로피롤[2,3-d]피리미딘-4-온유도체, 그의 제법 및 약학적 용도 | |
US5686442A (en) | Tricyclic benzazepine and benzothiazepine derivatives | |
CH674368A5 (no) | ||
FI79319B (fi) | Foerfarande foer framstaellning av nya terapeutiskt anvaendbara tricykliska oxindolkarboxamidderivat. | |
FI95259B (fi) | Menetelmä farmaseuttisesti aktiivisten 7-substituoitu-2-amino-3,5-dihydro-4H-pyrrolo/3,2-d/pyrimidin-4-onien valmistamiseksi | |
JP2003525227A (ja) | 4−ピリジル−および2,4−ピリミジニル−置換ピロール誘導体および薬学におけるそれらの利用法 | |
HUT62888A (en) | Process for producing new oxazole derivatives and pharmaceutical compositions comprising same | |
IE47902B1 (en) | Thiazolidine-2,4-dione derivatives | |
KR20000075641A (ko) | 세로토닌-2 수용체 길항작용 및 알파 1-저해 작용을 갖는 피롤로티아진 및 피롤로티아제핀 화합물 | |
AU616608B2 (en) | 4,5,6,7-tetrasubstituted benzoxazolones | |
US4927970A (en) | Substituted 3-cyclobutene-1,2-dione intermediates | |
JPH04221386A (ja) | 4H−ピロロ[1,2−a]チエノ[2,3−f][1,4]ジアゼピンの新規誘導体、それらの製造方法及びこれらを含有する医薬品組成物 | |
Peesapati et al. | THIOPHENO [3, 2][1] BENZAZEPINE, BENZO [3, 4] CYCLOHEPTA [2, 1-b] THIOPHENES, THIAZOLO [5, 4-d][1] BENZAZEPINE AND BENZO [3, 4] CYCLOHEPTA [2, 1-d] THIAZOLES | |
KR20000075642A (ko) | 세로토닌-2 수용체 길항작용 및 알파 1-저해 작용을 갖는 피롤로티아진 및 피롤로티아제핀 화합물 | |
CA2396413A1 (en) | Fused pyrrole compounds, pharmaceutical agents containing the same, and the use thereof | |
EP0966473B1 (fr) | Thiazolobenzoheterocycles, leur preparation et les medicaments les contenant | |
FR2539131A1 (fr) | Nouvelles carboxy-thiazolo(3,2-a)pyrimidines substituees utiles notamment comme antiallergiques et leurs procedes de fabrication | |
Boulouard et al. | Pyirolothieno [1, 4] diazepines. Part IV. First synthesis of pyrrolo‐[1, 2‐a] thieno [2, 3‐f][1, 4] diazepine Derivatives | |
JP2000191663A (ja) | 縮合ピリダジン誘導体の製造法 | |
Binder et al. | Synthesis of thienoimidazothiazoles | |
JPH06293640A (ja) | 肝疾患治療剤および1,3−ベンゾキサチオール誘導体 | |
Erker et al. | Studies on the chemistry of thienoannelated O, N‐and S, N‐containing heterocycles. 24 [1]. Synthesis of imidazo [1, 5‐d] thieno [2, 3‐b][1, 4]‐thiazine derivatives as potential receptor ligands | |
JPH0120155B2 (no) |